Advertisement
Screener

Titan Pharmaceuticals, Inc. Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)

Titan Pharmaceuticals, Inc. Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)

Titan Pharmaceuticals, Inc. reported Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) of 80.00% for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-18.

Discontinued › Notes › Fair Value Measures and Disclosures

us-gaap:FairValueAssumptionsExpectedVolatilityRate · last filed 2013-03-18

  • Titan Pharmaceuticals, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2012 was 80.00%.
Period endFair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 6 monthFair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 9 monthFair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 12 month
2012-12-3180.00%
10-K · filed 2013-03-18
2012-09-3075.00%
10-Q · filed 2012-11-09
2012-06-3065.00%
10-Q · filed 2012-08-09